Corteva Inc (CTVA) is overvalued and Nutrien Ltd (NTR) is slightly undervalued.
Against our estimates of intrinsic value, NTR trades at the wider discount: a margin of safety of +10%, against -31% for CTVA.
Values as of the 22 Sept 2026 close.
Discounting its cash flows at 8.4% (average of 3 methods) values the shares at $61.32; the price of $80.34 is 31% above that value, and 78% of that value comes from beyond year five.
Leak Score 51/100 on 9 of 12 signals
Discounting its cash flows at 8.0% (average of 3 methods) values the shares at $83.76; the price of $75.43 is 10% below that value, and 79% of that value comes from beyond year five.
Leak Score 27/100 on 3 of 12 signals
| Metric | CTVA | NTR |
|---|---|---|
| Verdict | Overvalued | Slightly undervalued |
| Price | $80.34 | $75.43 |
| Intrinsic value | $61.32 | $83.76 |
| Margin of safety | -31% | +10% |
| Leak Score | 51/100 (9/12) | 27/100 (3/12) |
| Market cap | $53.6B | $36.0B |
| Revenue growth, 5 years | 4.1% | 5.2% |
| Operating margin | 16.7% | 13.8% |
| Net margin | 5.7% | 8.4% |
| Return on equity | 4.3% | 9.3% |
| Debt to equity | 0.19 | 0.49 |
| P/E | 53.1x | 15.3x |
| Forward P/E | 19.4x | 15.2x |
| P/B | 2.1x | 1.4x |
| Dividend yield | 0.9% | 2.9% |